Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responses
Various strategies have been developed to transfer tumor-specific antigens into antigen presenting cells in order to induce cytotoxic T cell responses against tumor cells. One approach uses cellular vaccines based on fusions of autologous antigen presenting cells and allogeneic tumor cells. The fusi...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 September 2011
|
| In: |
BMC cancer
Year: 2011, Jahrgang: 11, Pages: 1-10 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-11-410 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-11-410
|
| Verfasserangaben: | Yvette Garbe, Ulrike Klier and Michael Linnebacher |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1853054542 | ||
| 003 | DE-627 | ||
| 005 | 20240311114833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230719s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-11-410 |2 doi | |
| 035 | |a (DE-627)1853054542 | ||
| 035 | |a (DE-599)KXP1853054542 | ||
| 035 | |a (OCoLC)1425872334 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Garbe, Yvette |e VerfasserIn |0 (DE-588)1262031311 |0 (DE-627)1809456398 |4 aut | |
| 245 | 1 | 0 | |a Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responses |c Yvette Garbe, Ulrike Klier and Michael Linnebacher |
| 246 | 3 | 3 | |a Semiallogenic fusions of MSI+ tumor cells and activated B cells induce MSI-specific T cell responses |
| 264 | 1 | |c 26 September 2011 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.07.2023 | ||
| 500 | |a Im Titel ist das Pluszeichen "+" hochgestellt | ||
| 520 | |a Various strategies have been developed to transfer tumor-specific antigens into antigen presenting cells in order to induce cytotoxic T cell responses against tumor cells. One approach uses cellular vaccines based on fusions of autologous antigen presenting cells and allogeneic tumor cells. The fusion cells combine antigenicity of the tumor cell with optimal immunostimulatory capacity of the antigen presenting cells. | ||
| 650 | 4 | |a Cell fusion | |
| 650 | 4 | |a frameshift antigens | |
| 650 | 4 | |a microsatellite instability | |
| 650 | 4 | |a T cell epitopes | |
| 700 | 1 | |a Klier, Ulrike |d 1979- |e VerfasserIn |0 (DE-588)103527227X |0 (DE-627)747134049 |0 (DE-576)382888014 |4 aut | |
| 700 | 1 | |a Linnebacher, Michael |d 1969- |e VerfasserIn |0 (DE-588)1028873808 |0 (DE-627)731784960 |0 (DE-576)376314958 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 11(2011), Artikel-ID 410, Seite 1-10 |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responses |
| 773 | 1 | 8 | |g volume:11 |g year:2011 |g elocationid:410 |g pages:1-10 |g extent:10 |a Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responses |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2407-11-410 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230719 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1262031311 |a Garbe, Yvette |m 1262031311:Garbe, Yvette |p 1 |x j | ||
| 999 | |a KXP-PPN1853054542 |e 4355159957 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"id":{"zdb":["2041352-X"],"eki":["326643710"],"issn":["1471-2407"]},"origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","publisher":"BioMed Central ; Springer","dateIssuedKey":"2001","dateIssuedDisp":"2001-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"part":{"year":"2011","pages":"1-10","text":"11(2011), Artikel-ID 410, Seite 1-10","volume":"11","extent":"10"},"pubHistory":["1.2001 -"],"recId":"326643710","language":["eng"],"note":["Gesehen am 22.05.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responsesBMC cancer"}],"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Yvette Garbe, Ulrike Klier and Michael Linnebacher"]},"id":{"doi":["10.1186/1471-2407-11-410"],"eki":["1853054542"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"26 September 2011"}],"language":["eng"],"recId":"1853054542","note":["Gesehen am 17.07.2023","Im Titel ist das Pluszeichen \"+\" hochgestellt"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"titleAlt":[{"title":"Semiallogenic fusions of MSI+ tumor cells and activated B cells induce MSI-specific T cell responses"}],"person":[{"roleDisplay":"VerfasserIn","display":"Garbe, Yvette","role":"aut","family":"Garbe","given":"Yvette"},{"family":"Klier","given":"Ulrike","display":"Klier, Ulrike","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Linnebacher, Michael","given":"Michael","family":"Linnebacher"}],"title":[{"title":"Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responses","title_sort":"Semiallogenic fusions of MSI+tumor cells and activated B cells induce MSI-specific T cell responses"}]} | ||
| SRT | |a GARBEYVETTSEMIALLOGE2620 | ||